ORPH is currently covered by 1 analysts with average potential upside of $-0.97 (-12.03%) backed by 0 price targets and 1 ratings. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 75 days.
Most recent stock forecast was given by TAZEEN AHMAD from BAML on 30-Mar-2021.
Highest price target for ORPH is 7, Lowest price target is 7, average price target is 7.
Currently, out of the existing stock ratings of ORPH - 1 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Sell
5
$4.66 (1370.59%)
13
1 years 11 months 26 days ago
2/2 (100%)
$-0.97 (-12.03%)
75
What is ORPH(Orphazyme A/S Unsponsored ADR) average time for price targets to be met?
Which analyst has the current highest performing score on ORPH(Orphazyme A/S Unsponsored ADR) with a proven track record?
